General Information of the Compound
Compound ID
CP0435522
Compound Name
2-(3-benzyl-3H-inden-1-yl)-N-methylethanamine
    Show/Hide
Synonyms
CHEMBL194174
[2-(3-Benzyl-3H-inden-1-yl)-ethyl]-methyl-amine
    Show/Hide
Structure
Formula
C19H21N
Molecular Weight
263.384
Canonical SMILES
CNCCC1=CC(Cc2ccccc2)c2ccccc12
    Show/Hide
InChI
InChI=1S/C19H21N/c1-20-12-11-16-14-17(13-15-7-3-2-4-8-15)19-10-6-5-9-18(16)19/h2-10,14,17,20H,11-13H2,1H3
    Show/Hide
InChIKey
UHYPQIJLHJTNMK-UHFFFAOYSA-N
Physicochemical Property
logP
4.0194
Rotatable Bonds
5
Heavy Atom Count
20
Polar Areas
12.03
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
1
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44401277
ChEMBL ID
CHEMBL194174
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 3 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( [2-(3-Benzyl-3H-inden-1-yl)-ethyl]-methyl-amine )
Drug Name [2-(3-Benzyl-3H-inden-1-yl)-ethyl]-methyl-amine
Target(s)
5-HT 6 receptor (HTR6)
Inhibitor